Response from the company "We appreciate the confidence you have placed in us with your investment.
It has been a tough month for my Team, as we work through this.
Our main focus as you can understand is our customers and communicating with them.
It is important to note that we will be issuing the Q1 financial statements before the close of January, 2017.
As for the future, we have implemented several operating procedures that ensure it cannot happen again.
The inputs, products we use in our facility, are now tested to ensure them are not contaminated, and we test all product before we sell it to our patients.
We have encouraged Health Canada to change the rules to enhance testing, and look forward to coming out of this unfortunate event stronger.
As we in Life, in Business, are not defined by one event…..Organigram will hopefully be looked at long term and will continue to deliver shareholder value for those that take a long term outlook."